Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Nanda, Kavita"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
    Autorzy:
    Harryparsad R; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Meyer B; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Taku O; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Serrano M; Virginia Commonwealth University, Richmond, Virginia, United State of America.
    Chen PL; FHI 360, Durham, North Carolina, United States of America.
    Gao X; FHI 360, Durham, North Carolina, United States of America.
    Williamson AL; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Mehou-Loko C; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    d'Hellencourt FL; FHI 360, Durham, North Carolina, United States of America.
    Smit J; MRU, University of the Witwatersrand, Durban, South Africa.
    Strauss J; Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA, United States of America.
    Nanda K; FHI 360, Durham, North Carolina, United States of America.
    Ahmed K; Setshaba Research Centre, Pretoria, South Africa.; Faculty of Health Sciences, Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa8 Pfizer, Inc., Pennsylvania, PA, United States of America.
    Beksinska M; MRU, University of the Witwatersrand, Durban, South Africa.
    Buck G; Virginia Commonwealth University, Richmond, Virginia, United State of America.
    Morrison C; FHI 360, Durham, North Carolina, United States of America.
    Deese J; Disease Elimination Program, Life Sciences Discipline, Burnet Institute, Melbourne, Australia.
    Masson L; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Central Clinical School, Monash University, Melbourne, Australia.; Faculty of Health Sciences, Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa8 Pfizer, Inc., Pennsylvania, PA, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Nov 10; Vol. 18 (11), pp. e0294285. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).
    Typ publikacji:
    Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Sexually Transmitted Diseases*/prevention & control
    Trichomonas vaginalis*
    HIV Infections*/epidemiology
    HIV Infections*/prevention & control
    Chlamydia Infections*/epidemiology
    Chlamydia Infections*/diagnosis
    Male ; Humans ; Female ; Adolescent ; Young Adult ; Adult ; South Africa/epidemiology ; Contraceptive Agents ; Prevalence ; Incidence ; Chlamydia trachomatis ; Neisseria gonorrhoeae
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Genital inflammatory status and the innate immune response to contraceptive initiation.
    Autorzy:
    Radzey N; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Harryparsad R; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Meyer B; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Chen PL; FHI 360, Durham, North Carolina, USA.
    Gao X; FHI 360, Durham, North Carolina, USA.
    Morrison C; FHI 360, Durham, North Carolina, USA.
    Taku O; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Williamson AL; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Mehou-Loko C; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
    Lefebvre d'Hellencourt F; FHI 360, Durham, North Carolina, USA.
    Buck G; Virginia Commonwealth University, Richmond, Virginia, USA.
    Smit J; MatCH Research Unit (MRU), Department of Obstetrics and Gynaecology, University of the Witwatersrand, Durban, South Africa.
    Strauss J; Virginia Commonwealth University, Richmond, Virginia, USA.
    Nanda K; FHI 360, Durham, North Carolina, USA.
    Ahmed K; Setshaba Research Centre, Tshwane, South Africa.; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
    Beksinska M; MatCH Research Unit (MRU), Department of Obstetrics and Gynaecology, University of the Witwatersrand, Durban, South Africa.
    Serrano M; Virginia Commonwealth University, Richmond, Virginia, USA.
    Bailey V; Setshaba Research Centre, Tshwane, South Africa.
    Masson L; Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.; Disease Elimination Program, Life Sciences Discipline, Burnet Institute, Melbourne, Australia.; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Central Clinical School, Monash University, Melbourne, Australia.
    Deese J; RTI International, Research Triangle Park, North Carolina, USA.
    Pokaż więcej
    Źródło:
    American journal of reproductive immunology (New York, N.Y. : 1989) [Am J Reprod Immunol] 2022 Aug; Vol. 88 (2), pp. e13542. Date of Electronic Publication: 2022 Apr 20.
    Typ publikacji:
    Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
    MeSH Terms:
    Contraceptive Agents, Female*/adverse effects
    Contraceptive Agents, Female*/pharmacology
    HIV Infections*/epidemiology
    Cytokines ; Female ; Genitalia ; Humans ; Immunity, Innate ; Inflammation ; Intrauterine Devices, Copper/adverse effects ; Levonorgestrel/adverse effects ; Levonorgestrel/pharmacology ; Medroxyprogesterone Acetate/adverse effects ; Medroxyprogesterone Acetate/pharmacology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report.
    Autorzy:
    Malahleha M; Setshaba Research Centre, 2088 Block H, Soshanguve, Pretoria, 0152, South Africa. .
    Ahmed K; Setshaba Research Centre, 2088 Block H, Soshanguve, Pretoria, 0152, South Africa. .
    Deese J; FHI 360, 359 Blackwell Street, Suite 200, Durham, NC, 27701, USA. .
    Nanda K; FHI 360, 359 Blackwell Street, Suite 200, Durham, NC, 27701, USA. .
    van Damme L; Bill and Melinda Gates Foundation, 500 Fifth Avenue North, Seattle, WA, 98109, USA. .
    De Baetselier I; Institute of Tropical Medicine, Nationalestraat 155, Antwerpen, 2000, Belgium. .
    Burnett RJ; HIV and Hepatitis Research Unit, Department of Virology, University of Limpopo, Medunsa Campus, PO Box 173, Medunsa, Pretoria, 0204, South Africa. .
    Pokaż więcej
    Źródło:
    Journal of medical case reports [J Med Case Rep] 2015 Sep 28; Vol. 9, pp. 207. Date of Electronic Publication: 2015 Sep 28.
    Typ publikacji:
    Case Reports; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents/*administration & dosage
    Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*administration & dosage
    HIV Infections/*prevention & control
    Hepatitis B Antibodies/*drug effects
    Hepatitis B virus/*physiology
    Hepatitis B, Chronic/*immunology
    Liver/*immunology
    Virus Activation/*drug effects
    Adult ; Alanine Transaminase/metabolism ; Anti-HIV Agents/adverse effects ; Clinical Trials as Topic ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/adverse effects ; Female ; HIV Infections/immunology ; Hepatitis B/immunology ; Hepatitis B Antibodies/immunology ; Hepatitis B, Chronic/diagnosis ; Humans ; Practice Guidelines as Topic ; Pre-Exposure Prophylaxis/methods ; Retrospective Studies ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.
    Autorzy:
    Feldblum PJ; Family Health International, Research Triangle Park, North Carolina, USA. />Adeiga A
    Bakare R
    Wevill S
    Lendvay A
    Obadaki F
    Olayemi MO
    Wang L
    Nanda K
    Rountree W
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2008 Jan 23; Vol. 3 (1), pp. e1474. Date of Electronic Publication: 2008 Jan 23.
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Vagina*
    HIV Infections/*prevention & control
    Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Double-Blind Method ; Female ; Gels ; HIV Infections/transmission ; Humans ; Male ; Nigeria ; Patient Compliance ; Placebos ; Sexual Behavior
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial.
    Autorzy:
    Peterson, Leigh
    Taylor, Doug
    Roddy, Ronald
    Belai, Ghiorghis
    Phillips, Pamela
    Nanda, Kavita
    Grant, Robert
    Clarke, Edith Essie Kekawo
    Doh, Anderson Sama
    Ridzon, Renee
    Jaffe, Howard S.
    Cates, Willard
    Pokaż więcej
    Temat:
    DRUG efficacy
    ANTIVIRAL agents
    HIV infections
    DISEASES in women
    PLACEBOS
    Źródło:
    PLoS Clinical Trials; May2007, Vol. 4 Issue 5, p0001-0009, 9p
    Terminy geograficzne:
    GHANA
    CAMEROON
    NIGERIA
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies